Atlas Trials

Allogeneic Mesenchymal Stem Cell-Derived Exosome Therapy for Progressive Multiple Sclerosis

Clinical trial NCT07146087 · SUSPENDED

Trial details

NCT number
NCT07146087
Sponsor
Biocells Medical
Status
SUSPENDED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Multiple Sclerosis
Start date
2020-07-01
Primary completion
2023-06-30
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.